

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | plasma membrane repair (GO:0001778) | 4.61772772 |
| 2 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.37979171 |
| 3 | sarcomere organization (GO:0045214) | 4.28777644 |
| 4 | muscle filament sliding (GO:0030049) | 3.80658353 |
| 5 | actin-myosin filament sliding (GO:0033275) | 3.80658353 |
| 6 | tricarboxylic acid cycle (GO:0006099) | 3.67534153 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 3.58471524 |
| 8 | negative regulation of protein localization to cell surface (GO:2000009) | 3.56218433 |
| 9 | cell adhesion mediated by integrin (GO:0033627) | 3.56095872 |
| 10 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.54961606 |
| 11 | fatty acid transmembrane transport (GO:1902001) | 3.47253715 |
| 12 | carnitine shuttle (GO:0006853) | 3.39169636 |
| 13 | lysine catabolic process (GO:0006554) | 3.33845399 |
| 14 | lysine metabolic process (GO:0006553) | 3.33845399 |
| 15 | cardiac myofibril assembly (GO:0055003) | 3.33807619 |
| 16 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.28789124 |
| 17 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.27412432 |
| 18 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.26222231 |
| 19 | low-density lipoprotein particle clearance (GO:0034383) | 3.25902125 |
| 20 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.20672427 |
| 21 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.20570890 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 3.18876249 |
| 23 | relaxation of smooth muscle (GO:0044557) | 3.18142193 |
| 24 | actin-mediated cell contraction (GO:0070252) | 3.17606449 |
| 25 | apoptotic cell clearance (GO:0043277) | 3.15288427 |
| 26 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.09164440 |
| 27 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.07498012 |
| 28 | heart trabecula formation (GO:0060347) | 3.06586849 |
| 29 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.06541306 |
| 30 | myofibril assembly (GO:0030239) | 3.06538447 |
| 31 | 2-oxoglutarate metabolic process (GO:0006103) | 3.05967867 |
| 32 | regulation of tight junction assembly (GO:2000810) | 3.02849811 |
| 33 | regulation of fatty acid oxidation (GO:0046320) | 2.97648980 |
| 34 | basement membrane organization (GO:0071711) | 2.95172274 |
| 35 | cellular ketone body metabolic process (GO:0046950) | 2.94365660 |
| 36 | actomyosin structure organization (GO:0031032) | 2.93440395 |
| 37 | regulation of sequestering of triglyceride (GO:0010889) | 2.88068109 |
| 38 | stress fiber assembly (GO:0043149) | 2.87614086 |
| 39 | NADH metabolic process (GO:0006734) | 2.83447837 |
| 40 | chondrocyte proliferation (GO:0035988) | 2.83247093 |
| 41 | fatty acid beta-oxidation (GO:0006635) | 2.80484673 |
| 42 | regulation of coenzyme metabolic process (GO:0051196) | 2.79971704 |
| 43 | regulation of cofactor metabolic process (GO:0051193) | 2.79971704 |
| 44 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.79008557 |
| 45 | endocardial cushion development (GO:0003197) | 2.78673463 |
| 46 | aspartate family amino acid catabolic process (GO:0009068) | 2.76125156 |
| 47 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.74744239 |
| 48 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.71279754 |
| 49 | endothelial cell morphogenesis (GO:0001886) | 2.68856094 |
| 50 | cell migration involved in heart development (GO:0060973) | 2.67940992 |
| 51 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.67359636 |
| 52 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.65951693 |
| 53 | L-phenylalanine metabolic process (GO:0006558) | 2.65951693 |
| 54 | epoxygenase P450 pathway (GO:0019373) | 2.65717837 |
| 55 | paraxial mesoderm development (GO:0048339) | 2.61901983 |
| 56 | positive regulation of fatty acid oxidation (GO:0046321) | 2.61687832 |
| 57 | L-amino acid import (GO:0043092) | 2.59327382 |
| 58 | protein targeting to plasma membrane (GO:0072661) | 2.57692205 |
| 59 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.57441091 |
| 60 | regulation of plasminogen activation (GO:0010755) | 2.56151970 |
| 61 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.55819437 |
| 62 | epithelial cell-cell adhesion (GO:0090136) | 2.55129848 |
| 63 | cellular response to interferon-alpha (GO:0035457) | 2.55059588 |
| 64 | neuronal action potential propagation (GO:0019227) | 2.54241519 |
| 65 | tricarboxylic acid metabolic process (GO:0072350) | 2.53524449 |
| 66 | oxaloacetate metabolic process (GO:0006107) | 2.53398505 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 2.53379769 |
| 68 | cardiac muscle cell development (GO:0055013) | 2.52913109 |
| 69 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.52649134 |
| 70 | lymphangiogenesis (GO:0001946) | 2.52547837 |
| 71 | alpha-linolenic acid metabolic process (GO:0036109) | 2.52095468 |
| 72 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.51523914 |
| 73 | cardiac muscle contraction (GO:0060048) | 2.50336980 |
| 74 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.49683275 |
| 75 | actin filament-based movement (GO:0030048) | 2.49202687 |
| 76 | ketone body metabolic process (GO:1902224) | 2.48435168 |
| 77 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48397375 |
| 78 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.48383089 |
| 79 | protein localization to endosome (GO:0036010) | 2.48312199 |
| 80 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.46681594 |
| 81 | fatty acid catabolic process (GO:0009062) | 2.46655172 |
| 82 | fatty acid oxidation (GO:0019395) | 2.46543119 |
| 83 | adhesion of symbiont to host cell (GO:0044650) | 2.46038834 |
| 84 | virion attachment to host cell (GO:0019062) | 2.46038834 |
| 85 | substrate-dependent cell migration (GO:0006929) | 2.45720131 |
| 86 | kidney mesenchyme development (GO:0072074) | 2.45549189 |
| 87 | retinal cone cell development (GO:0046549) | 2.45481280 |
| 88 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.45246122 |
| 89 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.44137324 |
| 90 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.44112315 |
| 91 | skeletal muscle fiber development (GO:0048741) | 2.43999170 |
| 92 | regulation of cell communication by electrical coupling (GO:0010649) | 2.43497104 |
| 93 | lipid oxidation (GO:0034440) | 2.43337101 |
| 94 | positive regulation of catecholamine secretion (GO:0033605) | 2.43185976 |
| 95 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.42791003 |
| 96 | regulation of female gonad development (GO:2000194) | 2.42588131 |
| 97 | regulation of fibrinolysis (GO:0051917) | 2.42421949 |
| 98 | platelet degranulation (GO:0002576) | 2.41653227 |
| 99 | carnitine transmembrane transport (GO:1902603) | 2.41438710 |
| 100 | cartilage morphogenesis (GO:0060536) | 2.41267762 |
| 101 | anterior/posterior axis specification, embryo (GO:0008595) | 2.41254020 |
| 102 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.41136777 |
| 103 | glyoxylate metabolic process (GO:0046487) | 2.40563643 |
| 104 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.40028306 |
| 105 | axon extension involved in axon guidance (GO:0048846) | 2.40028306 |
| 106 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.38666046 |
| 107 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.38091038 |
| 108 | positive regulation of muscle hypertrophy (GO:0014742) | 2.38091038 |
| 109 | pericardium development (GO:0060039) | 2.37258787 |
| 110 | glutamate secretion (GO:0014047) | 2.37154708 |
| 111 | central nervous system myelination (GO:0022010) | 2.37113955 |
| 112 | axon ensheathment in central nervous system (GO:0032291) | 2.37113955 |
| 113 | wound healing, spreading of epidermal cells (GO:0035313) | 2.37108449 |
| 114 | regulation of actin filament-based movement (GO:1903115) | 2.36578542 |
| 115 | endocytic recycling (GO:0032456) | 2.36568158 |
| 116 | acetyl-CoA metabolic process (GO:0006084) | 2.36445268 |
| 117 | positive regulation of male gonad development (GO:2000020) | 2.36418513 |
| 118 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.35986087 |
| 119 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.35463093 |
| 120 | protein carboxylation (GO:0018214) | 2.35192722 |
| 121 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.35192722 |
| 122 | axon extension (GO:0048675) | 2.35144586 |
| 123 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.34583564 |
| 124 | regulation of muscle hypertrophy (GO:0014743) | 2.34267434 |
| 125 | cardiac cell development (GO:0055006) | 2.33764475 |
| 126 | protein hydroxylation (GO:0018126) | 2.33432206 |
| 127 | creatine metabolic process (GO:0006600) | 2.33250761 |
| 128 | myotube cell development (GO:0014904) | 2.33237861 |
| 129 | regulation of cholesterol storage (GO:0010885) | 2.33062619 |
| 130 | membrane raft organization (GO:0031579) | 2.32920359 |
| 131 | regulation of macrophage chemotaxis (GO:0010758) | 2.32738469 |
| 132 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.32241518 |
| 133 | carnitine transport (GO:0015879) | 2.32218094 |
| 134 | amino-acid betaine transport (GO:0015838) | 2.32218094 |
| 135 | positive regulation of hemostasis (GO:1900048) | 2.32029337 |
| 136 | positive regulation of blood coagulation (GO:0030194) | 2.32029337 |
| 137 | metanephric mesenchyme development (GO:0072075) | 2.31844805 |
| 138 | peptidyl-proline hydroxylation (GO:0019511) | 2.31825145 |
| 139 | negative regulation of cell size (GO:0045792) | 2.31600475 |
| 140 | negative regulation of vascular permeability (GO:0043116) | 2.30935515 |
| 141 | relaxation of muscle (GO:0090075) | 2.29468668 |
| 142 | response to muscle activity (GO:0014850) | 2.29068837 |
| 143 | regulation of dendritic spine development (GO:0060998) | 2.28744836 |
| 144 | muscle cell fate commitment (GO:0042693) | 2.28714108 |
| 145 | neuron projection extension (GO:1990138) | 2.26618596 |
| 146 | amino acid import (GO:0043090) | 2.25872982 |
| 147 | sodium ion export (GO:0071436) | 2.25773061 |
| 148 | ventricular septum development (GO:0003281) | 2.25178058 |
| 149 | smooth muscle tissue development (GO:0048745) | 2.24676207 |
| 150 | hippo signaling (GO:0035329) | 2.24547956 |
| 151 | cellular potassium ion homeostasis (GO:0030007) | 2.24266658 |
| 152 | collagen fibril organization (GO:0030199) | 2.24075805 |
| 153 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.23200532 |
| 154 | muscle cell cellular homeostasis (GO:0046716) | 2.23158039 |
| 155 | regulation of DNA methylation (GO:0044030) | 2.21245268 |
| 156 | regulation of relaxation of muscle (GO:1901077) | 2.21192968 |
| 157 | tooth mineralization (GO:0034505) | 2.20508400 |
| 158 | postsynaptic membrane organization (GO:0001941) | 2.18630180 |
| 159 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.18328401 |
| 160 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.13527883 |
| 161 | clathrin coat assembly (GO:0048268) | 2.12889629 |
| 162 | interkinetic nuclear migration (GO:0022027) | 2.12242267 |
| 163 | regulation of muscle adaptation (GO:0043502) | 2.11048277 |
| 164 | membrane assembly (GO:0071709) | 2.10533855 |
| 165 | urinary tract smooth muscle contraction (GO:0014848) | 2.09761167 |
| 166 | muscle contraction (GO:0006936) | 2.08438991 |
| 167 | skin morphogenesis (GO:0043589) | 2.07612705 |
| 168 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.07506003 |
| 169 | regulation of the force of heart contraction (GO:0002026) | 2.07312697 |
| 170 | negative regulation of cardiac muscle hypertrophy (GO:0010614) | 2.06914582 |
| 171 | relaxation of cardiac muscle (GO:0055119) | 2.06881905 |
| 172 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.06504219 |
| 173 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.06201395 |
| 174 | positive regulation of dendritic spine development (GO:0060999) | 2.05768620 |
| 175 | neuron remodeling (GO:0016322) | 2.05154781 |
| 176 | response to magnesium ion (GO:0032026) | 2.04236010 |
| 177 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.02920455 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.74306586 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.83782650 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.83569382 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 4.37689408 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.82387286 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.38524184 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.34818538 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.21567489 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.09261802 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.94457151 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.72735615 |
| 12 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.60495410 |
| 13 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59512273 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.32893570 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.24592607 |
| 16 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.20824595 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.20713833 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.14764720 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.12444878 |
| 20 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.02309197 |
| 21 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.99048012 |
| 22 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.97508856 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97503359 |
| 24 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.96095394 |
| 25 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.92758279 |
| 26 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.90398584 |
| 27 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89561556 |
| 28 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.88811198 |
| 29 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.87743110 |
| 30 | TP53_16413492_ChIP-PET_HCT116_Human | 1.86987869 |
| 31 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.85539015 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.83786840 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.82029593 |
| 34 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.79772940 |
| 35 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.78592344 |
| 36 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.76600046 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75112873 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.72464327 |
| 39 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.72038336 |
| 40 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.71354817 |
| 41 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.70663565 |
| 42 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.69708194 |
| 43 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.69708194 |
| 44 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.69558223 |
| 45 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69307413 |
| 46 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66642528 |
| 47 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64704004 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.62937512 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62924858 |
| 50 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.61497881 |
| 51 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.61497881 |
| 52 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61168133 |
| 53 | CJUN_26792858_Chip-Seq_BT549_Human | 1.59869159 |
| 54 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.59695161 |
| 55 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.57376953 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.57023118 |
| 57 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.53304533 |
| 58 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.53271445 |
| 59 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.49430620 |
| 60 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.48211996 |
| 61 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.48204260 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.47761285 |
| 63 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.47572341 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.47217588 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.47145313 |
| 66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46538140 |
| 67 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.46492839 |
| 68 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.45351359 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.45351359 |
| 70 | P300_19829295_ChIP-Seq_ESCs_Human | 1.44452488 |
| 71 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44137146 |
| 72 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.42598408 |
| 73 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.40869461 |
| 74 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39351892 |
| 75 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39009325 |
| 76 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.38553763 |
| 77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37341166 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.36801009 |
| 79 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36540709 |
| 80 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.36460878 |
| 81 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36390344 |
| 82 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.35975595 |
| 83 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.35812728 |
| 84 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35258575 |
| 85 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.34995094 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34330150 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.32971427 |
| 88 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.30857475 |
| 89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.29210161 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28383591 |
| 91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28069552 |
| 92 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.27842710 |
| 93 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27412475 |
| 94 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.27214499 |
| 95 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26686804 |
| 96 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26400318 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.26340309 |
| 98 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.25817325 |
| 99 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.25569208 |
| 100 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.25242801 |
| 101 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.24832010 |
| 102 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24717103 |
| 103 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23969297 |
| 104 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21902323 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21704352 |
| 106 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.20131493 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19765337 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.19360267 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18662184 |
| 110 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17763231 |
| 111 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.17312394 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.17256629 |
| 113 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.17179194 |
| 114 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17013597 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16354522 |
| 116 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15704299 |
| 117 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.15033243 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 1.14961039 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14454072 |
| 120 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14054582 |
| 121 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.13527892 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.13092351 |
| 123 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.12844656 |
| 124 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.12514831 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.11809173 |
| 126 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10966262 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10966262 |
| 128 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10898568 |
| 129 | TCF4_23295773_ChIP-Seq_U87_Human | 1.10229168 |
| 130 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.08886904 |
| 131 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07644003 |
| 132 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.06651025 |
| 133 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.05800442 |
| 134 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05154758 |
| 135 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.05020969 |
| 136 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04174282 |
| 137 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.04046313 |
| 138 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03541349 |
| 139 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02259947 |
| 140 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01527311 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01313420 |
| 142 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00957917 |
| 143 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00890562 |
| 144 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.00890562 |
| 145 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.99958058 |
| 146 | FUS_26573619_Chip-Seq_HEK293_Human | 0.99606993 |
| 147 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99500772 |
| 148 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.99452731 |
| 149 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99252008 |
| 150 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.98641804 |
| 151 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98382875 |
| 152 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.98283513 |
| 153 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97833418 |
| 154 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97678417 |
| 155 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97667441 |
| 156 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96812563 |
| 157 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96703787 |
| 158 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96069004 |
| 159 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95573285 |
| 160 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94490846 |
| 161 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94445840 |
| 162 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94151473 |
| 163 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.93058036 |
| 164 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92770715 |
| 165 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.91322075 |
| 166 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.90945340 |
| 167 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.90385609 |
| 168 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.89804803 |
| 169 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.88165691 |
| 170 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87551091 |
| 171 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87207845 |
| 172 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87156259 |
| 173 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86607616 |
| 174 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85194704 |
| 175 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84617156 |
| 176 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.83281088 |
| 177 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.82210382 |
| 178 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.81569628 |
| 179 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81405797 |
| 180 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.80499582 |
| 181 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.79132836 |
| 182 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78909857 |
| 183 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78331007 |
| 184 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.77613704 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.39802032 |
| 2 | MP0004084_abnormal_cardiac_muscle | 3.20344329 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.06245718 |
| 4 | MP0000751_myopathy | 2.96214545 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 2.86430770 |
| 6 | MP0000749_muscle_degeneration | 2.78917975 |
| 7 | MP0003279_aneurysm | 2.72238497 |
| 8 | MP0004130_abnormal_muscle_cell | 2.67435337 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.65355087 |
| 10 | MP0005360_urolithiasis | 2.47741624 |
| 11 | MP0005330_cardiomyopathy | 2.43897725 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.42712679 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.42249273 |
| 14 | MP0009840_abnormal_foam_cell | 2.36293400 |
| 15 | MP0009780_abnormal_chondrocyte_physiolo | 2.21659852 |
| 16 | MP0003646_muscle_fatigue | 2.21433427 |
| 17 | MP0004087_abnormal_muscle_fiber | 2.11044171 |
| 18 | MP0000747_muscle_weakness | 2.06374239 |
| 19 | MP0000750_abnormal_muscle_regeneration | 2.02961173 |
| 20 | MP0004215_abnormal_myocardial_fiber | 2.01348424 |
| 21 | MP0002972_abnormal_cardiac_muscle | 1.91735149 |
| 22 | MP0005620_abnormal_muscle_contractility | 1.91288588 |
| 23 | MP0003806_abnormal_nucleotide_metabolis | 1.91067751 |
| 24 | MP0002269_muscular_atrophy | 1.87897513 |
| 25 | MP0004272_abnormal_basement_membrane | 1.87632633 |
| 26 | MP0008775_abnormal_heart_ventricle | 1.85903957 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.85336426 |
| 28 | MP0005623_abnormal_meninges_morphology | 1.84868029 |
| 29 | MP0000013_abnormal_adipose_tissue | 1.82780121 |
| 30 | MP0005257_abnormal_intraocular_pressure | 1.81844009 |
| 31 | MP0010030_abnormal_orbit_morphology | 1.80816800 |
| 32 | MP0001299_abnormal_eye_distance/ | 1.79190847 |
| 33 | MP0004270_analgesia | 1.78239764 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.77727704 |
| 35 | MP0002139_abnormal_hepatobiliary_system | 1.77463211 |
| 36 | MP0001544_abnormal_cardiovascular_syste | 1.76321552 |
| 37 | MP0005385_cardiovascular_system_phenoty | 1.76321552 |
| 38 | MP0006138_congestive_heart_failure | 1.74846286 |
| 39 | MP0000343_altered_response_to | 1.69559287 |
| 40 | MP0005085_abnormal_gallbladder_physiolo | 1.62895929 |
| 41 | MP0005275_abnormal_skin_tensile | 1.60474318 |
| 42 | MP0010630_abnormal_cardiac_muscle | 1.57632945 |
| 43 | MP0004484_altered_response_of | 1.56932328 |
| 44 | MP0003879_abnormal_hair_cell | 1.56531416 |
| 45 | MP0001879_abnormal_lymphatic_vessel | 1.53413435 |
| 46 | MP0002332_abnormal_exercise_endurance | 1.52650928 |
| 47 | MP0003828_pulmonary_edema | 1.51619649 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.50818105 |
| 49 | MP0009250_abnormal_appendicular_skeleto | 1.49560765 |
| 50 | MP0005670_abnormal_white_adipose | 1.48333654 |
| 51 | MP0000759_abnormal_skeletal_muscle | 1.46618694 |
| 52 | MP0009384_cardiac_valve_regurgitation | 1.45394501 |
| 53 | MP0003091_abnormal_cell_migration | 1.42974754 |
| 54 | MP0002106_abnormal_muscle_physiology | 1.42906975 |
| 55 | MP0004145_abnormal_muscle_electrophysio | 1.37889739 |
| 56 | MP0003941_abnormal_skin_development | 1.37791852 |
| 57 | MP0005023_abnormal_wound_healing | 1.37524811 |
| 58 | MP0001958_emphysema | 1.36377134 |
| 59 | MP0005083_abnormal_biliary_tract | 1.35617054 |
| 60 | MP0003718_maternal_effect | 1.33618422 |
| 61 | MP0002108_abnormal_muscle_morphology | 1.33394622 |
| 62 | MP0005165_increased_susceptibility_to | 1.32789249 |
| 63 | MP0004233_abnormal_muscle_weight | 1.32068710 |
| 64 | MP0000778_abnormal_nervous_system | 1.31189955 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30470471 |
| 66 | MP0003252_abnormal_bile_duct | 1.29164932 |
| 67 | MP0005365_abnormal_bile_salt | 1.28348212 |
| 68 | MP0005332_abnormal_amino_acid | 1.25126751 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.23041151 |
| 70 | MP0010329_abnormal_lipoprotein_level | 1.22266266 |
| 71 | MP0003880_abnormal_central_pattern | 1.21289322 |
| 72 | MP0005369_muscle_phenotype | 1.21082002 |
| 73 | MP0004859_abnormal_synaptic_plasticity | 1.19672604 |
| 74 | MP0002295_abnormal_pulmonary_circulatio | 1.18636342 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 1.18415796 |
| 76 | MP0004510_myositis | 1.16054112 |
| 77 | MP0000767_abnormal_smooth_muscle | 1.15949961 |
| 78 | MP0002896_abnormal_bone_mineralization | 1.15919629 |
| 79 | MP0004185_abnormal_adipocyte_glucose | 1.14560025 |
| 80 | MP0003635_abnormal_synaptic_transmissio | 1.13576581 |
| 81 | MP0005187_abnormal_penis_morphology | 1.13208682 |
| 82 | MP0003950_abnormal_plasma_membrane | 1.12869890 |
| 83 | MP0003137_abnormal_impulse_conducting | 1.11416580 |
| 84 | MP0002272_abnormal_nervous_system | 1.10605179 |
| 85 | MP0000762_abnormal_tongue_morphology | 1.09946884 |
| 86 | MP0004885_abnormal_endolymph | 1.09662177 |
| 87 | MP0001486_abnormal_startle_reflex | 1.08863280 |
| 88 | MP0005595_abnormal_vascular_smooth | 1.08274038 |
| 89 | MP0005503_abnormal_tendon_morphology | 1.06316389 |
| 90 | MP0000534_abnormal_ureter_morphology | 1.06082186 |
| 91 | MP0008875_abnormal_xenobiotic_pharmacok | 1.03725632 |
| 92 | MP0004085_abnormal_heartbeat | 1.02998293 |
| 93 | MP0005319_abnormal_enzyme/_coenzyme | 1.02563028 |
| 94 | MP0002128_abnormal_blood_circulation | 1.02156483 |
| 95 | MP0006292_abnormal_olfactory_placode | 1.01170243 |
| 96 | MP0000604_amyloidosis | 1.01094955 |
| 97 | MP0005375_adipose_tissue_phenotype | 1.01047945 |
| 98 | MP0000249_abnormal_blood_vessel | 1.00702046 |
| 99 | MP0003329_amyloid_beta_deposits | 0.99649362 |
| 100 | MP0000230_abnormal_systemic_arterial | 0.99032690 |
| 101 | MP0003075_altered_response_to | 0.97770656 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.96445778 |
| 103 | MP0002971_abnormal_brown_adipose | 0.96387507 |
| 104 | MP0006036_abnormal_mitochondrial_physio | 0.95166943 |
| 105 | MP0001542_abnormal_bone_strength | 0.94434586 |
| 106 | MP0003633_abnormal_nervous_system | 0.91920515 |
| 107 | MP0000733_abnormal_muscle_development | 0.91446008 |
| 108 | MP0005164_abnormal_response_to | 0.90864824 |
| 109 | MP0002118_abnormal_lipid_homeostasis | 0.90226048 |
| 110 | MP0003755_abnormal_palate_morphology | 0.90061353 |
| 111 | MP0006054_spinal_hemorrhage | 0.89849419 |
| 112 | MP0005197_abnormal_uvea_morphology | 0.89572861 |
| 113 | MP0003303_peritoneal_inflammation | 0.89333995 |
| 114 | MP0001501_abnormal_sleep_pattern | 0.88988573 |
| 115 | MP0000428_abnormal_craniofacial_morphol | 0.88563407 |
| 116 | MP0005423_abnormal_somatic_nervous | 0.86307347 |
| 117 | MP0002734_abnormal_mechanical_nocicepti | 0.86268987 |
| 118 | MP0003195_calcinosis | 0.85721548 |
| 119 | MP0002064_seizures | 0.85559213 |
| 120 | MP0003942_abnormal_urinary_system | 0.84519793 |
| 121 | MP0001984_abnormal_olfaction | 0.84429061 |
| 122 | MP0000003_abnormal_adipose_tissue | 0.84253681 |
| 123 | MP0005084_abnormal_gallbladder_morpholo | 0.83058041 |
| 124 | MP0002572_abnormal_emotion/affect_behav | 0.82142270 |
| 125 | MP0010352_gastrointestinal_tract_polyps | 0.81043153 |
| 126 | MP0002063_abnormal_learning/memory/cond | 0.79314376 |
| 127 | MP0000920_abnormal_myelination | 0.79212173 |
| 128 | MP0003724_increased_susceptibility_to | 0.79130616 |
| 129 | MP0000609_abnormal_liver_physiology | 0.77136465 |
| 130 | MP0004142_abnormal_muscle_tone | 0.77088433 |
| 131 | MP0003385_abnormal_body_wall | 0.75702920 |
| 132 | MP0001533_abnormal_skeleton_physiology | 0.75429588 |
| 133 | MP0001614_abnormal_blood_vessel | 0.74827252 |
| 134 | MP0004883_abnormal_blood_vessel | 0.74807862 |
| 135 | MP0009643_abnormal_urine_homeostasis | 0.74382703 |
| 136 | MP0008004_abnormal_stomach_pH | 0.74147023 |
| 137 | MP0003634_abnormal_glial_cell | 0.73886768 |
| 138 | MP0001440_abnormal_grooming_behavior | 0.73833027 |
| 139 | MP0003631_nervous_system_phenotype | 0.73662196 |
| 140 | MP0000266_abnormal_heart_morphology | 0.73440190 |
| 141 | MP0001756_abnormal_urination | 0.73352638 |
| 142 | MP0003690_abnormal_glial_cell | 0.73160520 |
| 143 | MP0003045_fibrosis | 0.72595449 |
| 144 | MP0005551_abnormal_eye_electrophysiolog | 0.72502090 |
| 145 | MP0005508_abnormal_skeleton_morphology | 0.72109817 |
| 146 | MP0003935_abnormal_craniofacial_develop | 0.71029771 |
| 147 | MP0002234_abnormal_pharynx_morphology | 0.70807063 |
| 148 | MP0001293_anophthalmia | 0.69563980 |
| 149 | MP0009046_muscle_twitch | 0.69113372 |
| 150 | MP0010386_abnormal_urinary_bladder | 0.68770845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber splitting (HP:0003555) | 4.20863246 |
| 2 | Protrusio acetabuli (HP:0003179) | 3.96240506 |
| 3 | Exercise-induced muscle cramps (HP:0003710) | 3.94577451 |
| 4 | Increased connective tissue (HP:0009025) | 3.82760420 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 3.79374654 |
| 6 | Premature rupture of membranes (HP:0001788) | 3.63563846 |
| 7 | Cerebral aneurysm (HP:0004944) | 3.49932918 |
| 8 | Exercise-induced myalgia (HP:0003738) | 3.47118910 |
| 9 | Sudden death (HP:0001699) | 3.45196079 |
| 10 | Myoglobinuria (HP:0002913) | 3.31850546 |
| 11 | Asymmetric septal hypertrophy (HP:0001670) | 3.23047387 |
| 12 | Ventricular tachycardia (HP:0004756) | 3.18155259 |
| 13 | EMG: myopathic abnormalities (HP:0003458) | 3.17052225 |
| 14 | Difficulty climbing stairs (HP:0003551) | 3.12991052 |
| 15 | Difficulty running (HP:0009046) | 2.97850048 |
| 16 | Myotonia (HP:0002486) | 2.93971800 |
| 17 | Right ventricular cardiomyopathy (HP:0011663) | 2.89279725 |
| 18 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.87945416 |
| 19 | Aortic aneurysm (HP:0004942) | 2.85513380 |
| 20 | Muscle fiber inclusion bodies (HP:0100299) | 2.85339324 |
| 21 | Systemic lupus erythematosus (HP:0002725) | 2.82108183 |
| 22 | Axonal loss (HP:0003447) | 2.82062947 |
| 23 | Overgrowth (HP:0001548) | 2.81751125 |
| 24 | Lipoatrophy (HP:0100578) | 2.80113207 |
| 25 | Type 1 muscle fiber predominance (HP:0003803) | 2.76225958 |
| 26 | Abnormality of the calf musculature (HP:0001430) | 2.74184289 |
| 27 | Neurofibrillary tangles (HP:0002185) | 2.74155980 |
| 28 | Calf muscle hypertrophy (HP:0008981) | 2.73102732 |
| 29 | Xanthomatosis (HP:0000991) | 2.72323008 |
| 30 | Muscle stiffness (HP:0003552) | 2.68693156 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 2.68490079 |
| 32 | Atrial fibrillation (HP:0005110) | 2.67183844 |
| 33 | Aortic dissection (HP:0002647) | 2.64954139 |
| 34 | Rhabdomyolysis (HP:0003201) | 2.62831854 |
| 35 | Aplasia of the musculature (HP:0100854) | 2.62208046 |
| 36 | Hip contracture (HP:0003273) | 2.61532617 |
| 37 | Deep venous thrombosis (HP:0002625) | 2.61445311 |
| 38 | Limited hip movement (HP:0008800) | 2.60121579 |
| 39 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.59690347 |
| 40 | Complement deficiency (HP:0004431) | 2.56531170 |
| 41 | Distal lower limb muscle weakness (HP:0009053) | 2.54720586 |
| 42 | Increased variability in muscle fiber diameter (HP:0003557) | 2.51583170 |
| 43 | Nemaline bodies (HP:0003798) | 2.49919241 |
| 44 | Primary atrial arrhythmia (HP:0001692) | 2.47144195 |
| 45 | Spinal rigidity (HP:0003306) | 2.43555516 |
| 46 | Distal arthrogryposis (HP:0005684) | 2.42256360 |
| 47 | Broad metatarsal (HP:0001783) | 2.41434491 |
| 48 | Supernumerary spleens (HP:0009799) | 2.41327418 |
| 49 | Supraventricular arrhythmia (HP:0005115) | 2.41240115 |
| 50 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.39558416 |
| 51 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.35998847 |
| 52 | Supraventricular tachycardia (HP:0004755) | 2.34359301 |
| 53 | Ulnar deviation of the wrist (HP:0003049) | 2.34077652 |
| 54 | Palpitations (HP:0001962) | 2.33211144 |
| 55 | Dilated cardiomyopathy (HP:0001644) | 2.25029172 |
| 56 | Round ear (HP:0100830) | 2.24086912 |
| 57 | Febrile seizures (HP:0002373) | 2.20548670 |
| 58 | Peritonitis (HP:0002586) | 2.20503452 |
| 59 | Scapular winging (HP:0003691) | 2.19013584 |
| 60 | Atonic seizures (HP:0010819) | 2.18538873 |
| 61 | Facial diplegia (HP:0001349) | 2.18300117 |
| 62 | Polycythemia (HP:0001901) | 2.18156192 |
| 63 | Limb-girdle muscle atrophy (HP:0003797) | 2.17590188 |
| 64 | Vertebral compression fractures (HP:0002953) | 2.17429255 |
| 65 | Ankle contracture (HP:0006466) | 2.17055335 |
| 66 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16712552 |
| 67 | Action tremor (HP:0002345) | 2.14707558 |
| 68 | Slender build (HP:0001533) | 2.13229346 |
| 69 | Abnormality of the Achilles tendon (HP:0005109) | 2.13166335 |
| 70 | Hypoglycemic coma (HP:0001325) | 2.12430193 |
| 71 | Bundle branch block (HP:0011710) | 2.10851230 |
| 72 | Hyperammonemia (HP:0001987) | 2.10307149 |
| 73 | Coronal craniosynostosis (HP:0004440) | 2.09245503 |
| 74 | Achilles tendon contracture (HP:0001771) | 2.07474685 |
| 75 | Dilatation of the ascending aorta (HP:0005111) | 2.07448053 |
| 76 | Abnormality of complement system (HP:0005339) | 2.06302820 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.05576837 |
| 78 | Distal upper limb amyotrophy (HP:0007149) | 2.05576837 |
| 79 | Hypolipoproteinemia (HP:0010981) | 2.04728622 |
| 80 | Skin nodule (HP:0200036) | 2.04526104 |
| 81 | Aneurysm (HP:0002617) | 2.03365685 |
| 82 | Hyperlipoproteinemia (HP:0010980) | 2.01111293 |
| 83 | Spondylolisthesis (HP:0003302) | 2.00560626 |
| 84 | Absent phalangeal crease (HP:0006109) | 2.00001313 |
| 85 | Gowers sign (HP:0003391) | 1.99004396 |
| 86 | Myocardial infarction (HP:0001658) | 1.98050536 |
| 87 | Tarsal synostosis (HP:0008368) | 1.98018629 |
| 88 | Lymphangioma (HP:0100764) | 1.97718024 |
| 89 | Fragile skin (HP:0001030) | 1.97547585 |
| 90 | Neonatal short-limb short stature (HP:0008921) | 1.97116181 |
| 91 | Glomerulonephritis (HP:0000099) | 1.96921183 |
| 92 | Wormian bones (HP:0002645) | 1.94789328 |
| 93 | Short 1st metacarpal (HP:0010034) | 1.93774430 |
| 94 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.93774430 |
| 95 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.93094067 |
| 96 | Synostosis involving bones of the feet (HP:0009140) | 1.93094067 |
| 97 | Shallow orbits (HP:0000586) | 1.91908904 |
| 98 | Ventricular arrhythmia (HP:0004308) | 1.91357037 |
| 99 | Subaortic stenosis (HP:0001682) | 1.91252990 |
| 100 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.91252990 |
| 101 | Abnormal atrioventricular conduction (HP:0005150) | 1.91179022 |
| 102 | Nonimmune hydrops fetalis (HP:0001790) | 1.90850472 |
| 103 | Knee flexion contracture (HP:0006380) | 1.89879757 |
| 104 | Ketosis (HP:0001946) | 1.89425982 |
| 105 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.88141579 |
| 106 | Wide anterior fontanel (HP:0000260) | 1.87781885 |
| 107 | Ketoacidosis (HP:0001993) | 1.87718248 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 1.87378976 |
| 109 | Vascular tortuosity (HP:0004948) | 1.86703869 |
| 110 | Mesangial abnormality (HP:0001966) | 1.85876811 |
| 111 | Cerebral hemorrhage (HP:0001342) | 1.84955479 |
| 112 | Areflexia of lower limbs (HP:0002522) | 1.83611561 |
| 113 | Rapidly progressive (HP:0003678) | 1.83347441 |
| 114 | Wrist flexion contracture (HP:0001239) | 1.82752783 |
| 115 | Syncope (HP:0001279) | 1.81807013 |
| 116 | Hypoplasia of the iris (HP:0007676) | 1.81592455 |
| 117 | Aortic valve stenosis (HP:0001650) | 1.80772330 |
| 118 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.79857863 |
| 119 | Nephritis (HP:0000123) | 1.79352104 |
| 120 | Atrophic scars (HP:0001075) | 1.78399176 |
| 121 | Striae distensae (HP:0001065) | 1.77746571 |
| 122 | Frequent falls (HP:0002359) | 1.77370013 |
| 123 | Calcaneovalgus deformity (HP:0001848) | 1.77098079 |
| 124 | Abnormal cartilage morphology (HP:0002763) | 1.76495121 |
| 125 | Cervical subluxation (HP:0003308) | 1.76108219 |
| 126 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.75468996 |
| 127 | Soft skin (HP:0000977) | 1.75334787 |
| 128 | Myopathic facies (HP:0002058) | 1.75005494 |
| 129 | Abnormality of the ischium (HP:0003174) | 1.74585139 |
| 130 | Neck muscle weakness (HP:0000467) | 1.74403599 |
| 131 | Cerebral inclusion bodies (HP:0100314) | 1.74376828 |
| 132 | Abnormality of carpal bone ossification (HP:0006257) | 1.74178598 |
| 133 | Muscular dystrophy (HP:0003560) | 1.73949201 |
| 134 | Atrioventricular block (HP:0001678) | 1.73798259 |
| 135 | Arterial tortuosity (HP:0005116) | 1.72280608 |
| 136 | Heart block (HP:0012722) | 1.71209295 |
| 137 | Abnormality of the foot musculature (HP:0001436) | 1.70943890 |
| 138 | Bladder diverticulum (HP:0000015) | 1.70087128 |
| 139 | Abnormal finger flexion creases (HP:0006143) | 1.66273889 |
| 140 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.65912755 |
| 141 | Dysmetric saccades (HP:0000641) | 1.65555849 |
| 142 | Deformed tarsal bones (HP:0008119) | 1.62949222 |
| 143 | Mitral regurgitation (HP:0001653) | 1.62839150 |
| 144 | Abnormality of the 1st metacarpal (HP:0010009) | 1.61879155 |
| 145 | Increased circulating renin level (HP:0000848) | 1.61554237 |
| 146 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.59202945 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.59202945 |
| 148 | Conjunctival telangiectasia (HP:0000524) | 1.58634946 |
| 149 | Hydroxyprolinuria (HP:0003080) | 1.57175256 |
| 150 | Abnormality of proline metabolism (HP:0010907) | 1.57175256 |
| 151 | Limb-girdle muscle weakness (HP:0003325) | 1.56673044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.56434805 |
| 2 | TRIB3 | 3.48225211 |
| 3 | KDR | 3.18936377 |
| 4 | AKT3 | 3.10628692 |
| 5 | TIE1 | 3.04780718 |
| 6 | PKN2 | 2.96471523 |
| 7 | TGFBR2 | 2.67303250 |
| 8 | NTRK2 | 2.60181522 |
| 9 | MYLK | 2.47043462 |
| 10 | BCKDK | 2.36535645 |
| 11 | EPHA4 | 2.29668547 |
| 12 | LIMK1 | 2.24857955 |
| 13 | MAP3K13 | 2.11807906 |
| 14 | DMPK | 2.05101888 |
| 15 | LATS2 | 2.02961605 |
| 16 | PHKG2 | 1.97483030 |
| 17 | PHKG1 | 1.97483030 |
| 18 | ERN1 | 1.94589702 |
| 19 | TESK1 | 1.86470786 |
| 20 | PDK2 | 1.85070004 |
| 21 | TESK2 | 1.71055970 |
| 22 | OBSCN | 1.67461887 |
| 23 | NEK1 | 1.65701849 |
| 24 | MARK1 | 1.65455784 |
| 25 | NTRK3 | 1.63372946 |
| 26 | LMTK2 | 1.58694913 |
| 27 | LATS1 | 1.55888245 |
| 28 | NEK9 | 1.50637249 |
| 29 | PDK3 | 1.48988293 |
| 30 | PDK4 | 1.48988293 |
| 31 | ACVR1B | 1.48765935 |
| 32 | PIK3CA | 1.46539581 |
| 33 | PAK3 | 1.37862416 |
| 34 | SIK1 | 1.36864730 |
| 35 | PTK2B | 1.32622799 |
| 36 | MAP2K3 | 1.32188912 |
| 37 | RIPK1 | 1.30331401 |
| 38 | PDGFRA | 1.29681504 |
| 39 | MAP3K11 | 1.29435183 |
| 40 | NME2 | 1.28078477 |
| 41 | STK3 | 1.26830878 |
| 42 | EPHB2 | 1.23409492 |
| 43 | KSR2 | 1.22338216 |
| 44 | PNCK | 1.19468220 |
| 45 | TGFBR1 | 1.14589082 |
| 46 | DDR2 | 1.12529433 |
| 47 | PAK2 | 1.12380193 |
| 48 | CDK12 | 1.10490225 |
| 49 | MAPKAPK3 | 1.10306578 |
| 50 | SCYL2 | 1.10086408 |
| 51 | PINK1 | 1.09723916 |
| 52 | MAP2K1 | 1.09047383 |
| 53 | TNIK | 1.08746474 |
| 54 | MOS | 1.06317950 |
| 55 | PIK3CG | 1.03440758 |
| 56 | STK39 | 1.01640553 |
| 57 | ERBB4 | 1.01310126 |
| 58 | TBK1 | 0.99860641 |
| 59 | MAPK12 | 0.98368581 |
| 60 | ARAF | 0.95733232 |
| 61 | ILK | 0.95183195 |
| 62 | PRKD1 | 0.95026172 |
| 63 | TRPM7 | 0.93754852 |
| 64 | PIM2 | 0.93230162 |
| 65 | RET | 0.92990713 |
| 66 | PTK2 | 0.92494042 |
| 67 | CAMK2A | 0.92066278 |
| 68 | EPHA2 | 0.91350595 |
| 69 | FER | 0.90860426 |
| 70 | PAK4 | 0.90534986 |
| 71 | ERBB3 | 0.90352386 |
| 72 | MINK1 | 0.90141550 |
| 73 | KSR1 | 0.89856306 |
| 74 | LRRK2 | 0.88956450 |
| 75 | MAP3K9 | 0.87179776 |
| 76 | CASK | 0.83769330 |
| 77 | DAPK3 | 0.81960223 |
| 78 | CAMK2B | 0.81752292 |
| 79 | SGK2 | 0.79155334 |
| 80 | BMX | 0.78982522 |
| 81 | ROCK1 | 0.77172597 |
| 82 | PDGFRB | 0.76648071 |
| 83 | PLK2 | 0.76397221 |
| 84 | ABL2 | 0.76129972 |
| 85 | DAPK2 | 0.75325517 |
| 86 | MAP2K4 | 0.72267162 |
| 87 | BRD4 | 0.71215816 |
| 88 | MAP3K5 | 0.70430069 |
| 89 | GRK7 | 0.69854030 |
| 90 | MUSK | 0.69103157 |
| 91 | PRKG2 | 0.68996787 |
| 92 | BMPR1B | 0.68169520 |
| 93 | PKN1 | 0.67950425 |
| 94 | MAPK7 | 0.67369422 |
| 95 | PRKG1 | 0.67242609 |
| 96 | CDK19 | 0.67241597 |
| 97 | TYRO3 | 0.65944925 |
| 98 | PBK | 0.65880831 |
| 99 | STK38L | 0.65337912 |
| 100 | FGFR4 | 0.64981850 |
| 101 | SGK3 | 0.64963947 |
| 102 | CDK5 | 0.63683162 |
| 103 | MARK3 | 0.62622660 |
| 104 | PDPK1 | 0.61395960 |
| 105 | PAK6 | 0.61199750 |
| 106 | FRK | 0.60327386 |
| 107 | PTK6 | 0.60057234 |
| 108 | EPHB1 | 0.59366410 |
| 109 | CAMK1D | 0.57769830 |
| 110 | CAMKK1 | 0.57407290 |
| 111 | STK38 | 0.57141326 |
| 112 | NTRK1 | 0.56022701 |
| 113 | CDK9 | 0.56015887 |
| 114 | CAMKK2 | 0.55586952 |
| 115 | MAP3K7 | 0.55209593 |
| 116 | STK24 | 0.54207588 |
| 117 | MAP3K6 | 0.54128905 |
| 118 | CAMK1 | 0.54052233 |
| 119 | MAP3K3 | 0.53601100 |
| 120 | NEK6 | 0.52738616 |
| 121 | ADRBK1 | 0.51910027 |
| 122 | PRKCE | 0.48095058 |
| 123 | WNK1 | 0.47401926 |
| 124 | MELK | 0.47322114 |
| 125 | SGK494 | 0.46746517 |
| 126 | SGK223 | 0.46746517 |
| 127 | TAOK1 | 0.46521265 |
| 128 | CAMK2G | 0.43963966 |
| 129 | MAPK10 | 0.43214263 |
| 130 | TYK2 | 0.43005960 |
| 131 | STK10 | 0.42162121 |
| 132 | CAMK2D | 0.41766215 |
| 133 | PRKACB | 0.40937255 |
| 134 | FGFR1 | 0.40881690 |
| 135 | WNK4 | 0.40789763 |
| 136 | OXSR1 | 0.37849108 |
| 137 | PDK1 | 0.37698369 |
| 138 | MAPK13 | 0.36824237 |
| 139 | BRSK2 | 0.36587644 |
| 140 | JAK1 | 0.34820189 |
| 141 | ROCK2 | 0.34332407 |
| 142 | MET | 0.32695093 |
| 143 | PRKD3 | 0.32019856 |
| 144 | EGFR | 0.31682114 |
| 145 | MAP3K1 | 0.31276523 |
| 146 | BLK | 0.30794548 |
| 147 | SRC | 0.30770480 |
| 148 | MAPKAPK2 | 0.30231851 |
| 149 | SIK3 | 0.29642546 |
| 150 | CDK14 | 0.27216628 |
| 151 | CDC42BPA | 0.26810753 |
| 152 | RAF1 | 0.26216969 |
| 153 | MAPKAPK5 | 0.26171342 |
| 154 | MTOR | 0.25936253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.50900213 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.01630824 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.95677972 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44468395 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42004057 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.21761639 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.11530001 |
| 8 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.06552351 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.06540008 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.04526989 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 1.95604737 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.88812335 |
| 13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82955992 |
| 14 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.77800935 |
| 15 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.76452182 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.71326166 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 1.70291641 |
| 18 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.69764944 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.64231074 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.59615961 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.58525607 |
| 22 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58069287 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.57971207 |
| 24 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.57770104 |
| 25 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55481985 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.54669442 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.54020584 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.50940804 |
| 29 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.50693679 |
| 30 | Nicotine addiction_Homo sapiens_hsa05033 | 1.50254452 |
| 31 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.49211785 |
| 32 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.48532196 |
| 33 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.44090082 |
| 34 | Insulin secretion_Homo sapiens_hsa04911 | 1.44075254 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.43577927 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.42155249 |
| 37 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.41963889 |
| 38 | Long-term potentiation_Homo sapiens_hsa04720 | 1.36715916 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33504888 |
| 40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.31357521 |
| 41 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.30538769 |
| 42 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.28277212 |
| 43 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27887260 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26336830 |
| 45 | Focal adhesion_Homo sapiens_hsa04510 | 1.25153081 |
| 46 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.24758632 |
| 47 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.21909400 |
| 48 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20401624 |
| 49 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.19927630 |
| 50 | Olfactory transduction_Homo sapiens_hsa04740 | 1.15902772 |
| 51 | Cocaine addiction_Homo sapiens_hsa05030 | 1.14641496 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 1.14588876 |
| 53 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10154962 |
| 54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.10051318 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.09728431 |
| 56 | Taste transduction_Homo sapiens_hsa04742 | 1.09154302 |
| 57 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.07907991 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.07433869 |
| 59 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.07260395 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04630624 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 1.04177163 |
| 62 | Melanogenesis_Homo sapiens_hsa04916 | 1.03963268 |
| 63 | Parkinsons disease_Homo sapiens_hsa05012 | 1.03532829 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 1.00438557 |
| 65 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.99791881 |
| 66 | Bile secretion_Homo sapiens_hsa04976 | 0.99393166 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.99067714 |
| 68 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98008353 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.95540004 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.94631192 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93997152 |
| 72 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.89211789 |
| 73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.89000515 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88843537 |
| 75 | Amoebiasis_Homo sapiens_hsa05146 | 0.88495166 |
| 76 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88083135 |
| 77 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85408609 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85357841 |
| 79 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.81310752 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.80655360 |
| 81 | Alzheimers disease_Homo sapiens_hsa05010 | 0.79383472 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.78845913 |
| 83 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.78135915 |
| 84 | Lysosome_Homo sapiens_hsa04142 | 0.77128668 |
| 85 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76839478 |
| 86 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.75874000 |
| 87 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.75812386 |
| 88 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75552534 |
| 89 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.74328968 |
| 90 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.74124159 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.73162481 |
| 92 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.72296036 |
| 93 | Shigellosis_Homo sapiens_hsa05131 | 0.72081666 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.71935688 |
| 95 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71897715 |
| 96 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.70897541 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.68987274 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.68852454 |
| 99 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.68524532 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.68433556 |
| 101 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.67367290 |
| 102 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66152309 |
| 103 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65994040 |
| 104 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65694021 |
| 105 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.65659764 |
| 106 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.65373565 |
| 107 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65314436 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65297703 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.65094830 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.64426230 |
| 111 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63413509 |
| 112 | Salmonella infection_Homo sapiens_hsa05132 | 0.63392950 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63219241 |
| 114 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62918077 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.62732481 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.61767034 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.61085313 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.60751693 |
| 119 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60398313 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60003664 |
| 121 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.59889072 |
| 122 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.59236561 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59184415 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.58694323 |
| 125 | Melanoma_Homo sapiens_hsa05218 | 0.58114068 |
| 126 | Platelet activation_Homo sapiens_hsa04611 | 0.57602984 |
| 127 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.56382573 |
| 128 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.55928781 |
| 129 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55766208 |
| 130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55249589 |
| 131 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54280744 |
| 132 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54254878 |
| 133 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.54202794 |
| 134 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53951291 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.53764177 |
| 136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.53608075 |
| 137 | Phagosome_Homo sapiens_hsa04145 | 0.53378829 |
| 138 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52124923 |
| 139 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.51913689 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51140606 |
| 141 | Pertussis_Homo sapiens_hsa05133 | 0.51015798 |
| 142 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50941725 |
| 143 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.50700331 |
| 144 | Basal transcription factors_Homo sapiens_hsa03022 | 0.50078278 |
| 145 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.50066046 |
| 146 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.49696835 |
| 147 | Tight junction_Homo sapiens_hsa04530 | 0.49112988 |
| 148 | Endocytosis_Homo sapiens_hsa04144 | 0.48578643 |
| 149 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47452130 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47297106 |
| 151 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46318352 |
| 152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44670136 |
| 153 | Gap junction_Homo sapiens_hsa04540 | 0.44395043 |
| 154 | Malaria_Homo sapiens_hsa05144 | 0.44103081 |
| 155 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42493290 |
| 156 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42316753 |
| 157 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.40172936 |
| 158 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.38774115 |
| 159 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37666430 |
| 160 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37370842 |
| 161 | Huntingtons disease_Homo sapiens_hsa05016 | 0.35924168 |
| 162 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35015642 |
| 163 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34620551 |
| 164 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.33438432 |
| 165 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.32761827 |

